Anthocleista Djalonensis (Anthocleista djalonensis): Benefits, Dosage, Safety & Evidence

Questions fréquentes

How does Anthocleista djalonensis lower blood sugar?

Anthocleista djalonensis contains iridoid glycosides, particularly gentiopicroside and swertiamarin, which are believed responsible for its glucose-lowering effects. These compounds may enhance insulin sensitivity and promote cellular glucose uptake. The plant also contains alkaloids that may support pancreatic beta-cell function. However, the precise mechanism remains under investigation. Current evidence is rated Level C, based primarily on animal studies and traditional use rather than controlled human clinical trials.

Can Anthocleista djalonensis be taken with diabetes medications?

Anthocleista djalonensis should not be combined with conventional hypoglycemic medications without medical supervision. The herb possesses documented blood sugar-lowering properties, and concurrent use with drugs like metformin, sulfonylureas, or insulin may cause additive effects leading to dangerous hypoglycemia. Symptoms include dizziness, confusion, sweating, and weakness. Patients on diabetes medications should consult a healthcare provider before adding this herb to their regimen.

What is the recommended dosage for Anthocleista djalonensis?

Traditional preparations typically use a decoction of bark or root, taken as 200ml three times daily for adults. The decoction is prepared by boiling approximately 10-15 grams of dried plant material in water for 15-20 minutes. Standardized commercial extracts are not widely available, making precise dosing challenging. Due to limited clinical evidence (Level C), users should start with lower doses and monitor blood glucose levels closely under professional guidance.

Is Anthocleista djalonensis safe during pregnancy?

Anthocleista djalonensis is considered unsafe during pregnancy and should be strictly avoided. Traditional evidence and pharmacological properties suggest potential for uterine stimulation and possible fetal harm. The blood sugar-lowering effects may also pose risks to both maternal and fetal health. Breastfeeding women should likewise avoid this herb due to insufficient safety data. Women who are pregnant, planning pregnancy, or nursing should consult a qualified healthcare provider.

What is Anthocleista djalonensis used for in traditional medicine?

Anthocleista djalonensis is one of West Africa's most widely used medicinal plants, traditionally employed for diabetes, malaria, fever, liver conditions, and skin diseases. The bark and roots are the primary medicinal parts used throughout the Guinea region. It is considered one of the most important antidiabetic plants in West African ethnomedicine. Evidence is rated Level C, indicating benefits are suggested by preliminary research and traditional use, but well-designed clinical trials remain limited.

Fiche d'information compilée à partir de PubMed

Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.

Compilé à partir de 24 articles PubMed · modèle : gemma4:31b

Résumé

Anthocleista djalonensis is a medicinal plant used in West African traditional medicine for treating conditions including diabetes, malaria, and epilepsy [PMID:23422334, PMID:28777735].

Contexte

Anthocleista djalonensis (A. Chev) is a plant species belonging to the Loganiaceae family, found in regions such as Nigeria, Cameroon, and Mali [PMID:23422334, PMID:28777735, PMID:16270940].

Usages traditionnels

Traditionally used in West Africa to treat malaria, hernia, hypertension, stomach aches, hemorrhoids, syphilis, and diabetes [PMID:23422334]. In Northern Cameroon, the root bark is used for epilepsy, migraine, insomnia, dementia, anxiety, and mood disorders [PMID:28777735]. It is also used as a remedy for acute appendicitis [PMID:41930243] and sexually transmitted diseases [PMID:15099860].

Composés actifs

Essential oils from the leaves contain alpha-humulene (31.9%), beta-caryophyllene (17.8%), humulene epoxide II (12.7%), and caryophyllene oxide (5.9%) [PMID:23513740]. Stem bark volatile oils include methyl palmitate, methyl oleate, methyl stearate, and palmitoleic acid [PMID:41930243].

Mécanisme d'action

Anticonvulsant activity is associated with the GABA-ergic pathway, affecting brain gamma-aminobutyric acid (GABA) concentration and GABA-T activity [PMID:28777735]. In vitro uterine inhibition is suggested to occur via a mixture of phytochemicals that inhibit oxytocin and CaCl2 induced contractions [PMID:20921974].

Preuves cliniques

Preuve DDiabetes

Ethanolic root extracts/fractions significantly reduced fasting blood glucose levels in alloxan-induced diabetic rats, showing activity greater than glibenclamide [PMID:23569950].

Preuve DEpilepsy/Convulsions

Aqueous root bark extract protected mice against bicuculline-, picrotoxin-, pilocarpine-, and pentylenetetrazole-induced seizures [PMID:28777735, PMID:34504535].

Preuve DMalaria

Ethanolic leaf (1000-3000 mg/kg/day) and stembark (220-660 mg/kg/day) extracts exhibited significant antiplasmodial/blood schizonticidal activity in mice infected with Plasmodium berghei berghei [PMID:20407556].

Preuve DBacterial Infections

Ethanolic and cold-water root extracts exhibited bacteriostatic activity against Gram-positive strains and bactericidal activity against Gram-negative strains [PMID:15099860]. Methanolic extracts inhibited growth of 72.7% of wound isolates [PMID:16226414].

Preuve DTesticular Inflammation

Methanol and aqueous ethanol root extracts inhibited serum and intra-testicular interleukin-6 and serum nitrite levels induced by lipopolysaccharide (LPS) in rats [PMID:31428909].

Synthèse des preuves

The evidence consists entirely of preclinical animal models (rats/mice) and in vitro studies; there are no human clinical trials provided.

Sources PubMed

1.PMID: 32648128 (2020) — Effect of Anthocleista djalonensis A. Chev Root Extract on Testis of Matured Rats. · Chinese journal of integrative medicine
2.PMID: 23422334 (2013) — Alpha-amylase inhibitory activity of two Anthocleista species and in vivo rat model anti-diabetic activities of Anthocleista djalonensis extracts and fractions. · Journal of ethnopharmacology
3.PMID: 28777735 (2017) — Evidence for the involvement of the GABA-ergic pathway in the anticonvulsant activity of the roots bark aqueous extract of Anthocleista djalonensis A. Chev. (Loganiaceae). · Journal of basic and clinical physiology and pharmacology
4.PMID: 23569950 (2012) — Antidiabetic activities of ethanolic extract and fraction of Anthocleista djalonensis. · Asian Pacific journal of tropical biomedicine
5.PMID: 34504535 (2021)

Anthocleista Djalonensis

Sources et citations

Calculer une dose sûre de Anthocleista Djalonensis